Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60)Michael Pfreundschuh, Markus Loeffler, Bernd Metzner et al.|The Lancet Oncology|2008Cited by 1.1k
A Biologic Definition of Burkitt's Lymphoma from Transcriptional and Genomic ProfilingMichael Hummel, Reiner Siebert, Stefan Bentink et al.|New England Journal of Medicine|2006Cited by 1k
Translocations activating IRF4 identify a subtype of germinal center-derived B-cell lymphoma affecting predominantly children and young adultsItziar Salaverría, Claudia Philipp, Ilske Oschlies et al.|Blood|2011Cited by 291
Biological characterization of adult MYC-translocation-positive mature B-cell lymphomas other than molecular Burkitt lymphomaSietse Aukema, Markus Kreuz, Christian Köhler et al.|Haematologica|2013Cited by 166
New insights into the biology and origin of mature aggressive B-cell lymphomas by combined epigenomic, genomic, and transcriptional profilingJosé I. Martín‐Subero, Markus Kreuz, Marina Bibikova et al.|Blood|2008Cited by 145